Despite the emergence of the pandemic H1N1 influenza A virus in 2009, seasonal H3N2 viruses continue to co-circulate in the population and may even predominate in the coming influenza season. We describe a specific minor groove binder TaqMan assay for H3N2 viruses with a detection limit of 16.5 standard DNA copies. Published by Elsevier Inc.
Influenza A virus infection, as endemic 'seasonal' influenza or pandemic influenza, remains a significant public health threat (Morens et al., 2009) . Human seasonal H3N2 influenza viruses are derived from the [1968] [1969] pandemic that killed about 1 million people worldwide (Cox & Subbarao, 2000) . Even with the re-emergence of seasonal H1N1 viruses in 1977 and their co-circulation with H3N2 viruses since then, H3N2 influenza viruses have been the dominant strains during most influenza seasons, and they have been the major cause of human influenza morbidity and mortality worldwide (Russell et al., 2008) . While the 2009 pandemic H1N1 virus quickly became the dominant influenza A virus subtype soon after its emergence in early spring 2009 (Morens et al., 2010) , H3N2 viruses continued to be isolated in the Southern Hemisphere during the 2009 influenza season, and the number of reports of seasonal H3N2 isolates started to increase again in the USA from late June and July 2010 (http://www.cdc.gov/flu/whatsnew.htm). This correlates with recent worldwide surveillance data showing that H3N2 viruses currently are the dominant influenza A virus subtype being isolated in China and Chile (http://www.cdc.gov/flu/international/activity.htm) (CDC, 2010) . With the transition from the pattern of pandemic 2009 H1N1 to a mixed seasonal influenza A virus circulation pattern, H3N2 viruses may once again become the dominant subtype (Morens et al., 2010) .
The co-circulation of influenza A viruses of seasonal H3N2, H1N1, and 2009 pandemic H1N1 strains, each with different antiviral sensitivity patterns (Layne et al., 2009) , and the continuing risk of human infection with the highly pathogenic avian influenza A (HPAI) H5N1 virus, further stresses the need for rapid diagnostic tests that provide subtype-specific information, both for the initiation of appropriate therapy and for ongoing surveillance efforts. After successfully developing a rapid and sensitive 1-tube method for subtype discrimination of pandemic H1N1 and seasonal H1N1 influenza A viruses (Wang et al., 2009) , we here applied a minor groove binder (MGB) probe for influenza A virus H3N2 detection using real-time polymerase chain reaction (PCR) in this study.
MGB probes are now widely used in TaqMan-based virological testing (Jimenez-Clavero et al., 2006; Kulesh et al., 2004) . These probes are conjugated with an MGB at the 3′ end. Because the MGB moiety stabilizes the hybridization of the probe with single-stranded DNA targets, it can increase the specificity and sensitivity of the reactions by raising the melting temperature and reducing the length of the probe. The TaqMan MGB probe also contains a quencher dye that does not emit fluorescence within the detectable wavelength so that it can provide greater accuracy in quantitation.
In this study, 436 hemagglutinin sequences of human H3N2 viruses from 2007 to 2009 were retrieved from GenBank, aligned, and analyzed using the sequence analysis program MacVector (Cary, NC, USA). Conserved regions were identified for primer and probe design (Table 1) with the ABI Primer Express 3.0 software (Applied Biosystems, Foster City, CA, USA). The primers and probe were synthesized at IDT (San Diego, CA, USA) and at Applied Biosystems, respectively. The probe was labeled with the fluorescent reporter NED at the 5′ end and conjugated with the MGB at the 3′ end. Degenerate consensus primers were designed to amplify a selected 69-base pair hemagglutinin fragment (Table 1) .
Viruses were propagated in Madin-Darby canine kidney cells and viral RNA was isolated using the QIAamp viral RNA extraction kit (Qiagen, Valencia, CA, USA). For 2-step TaqMan PCR, first-strand cDNA was synthesized using random primers as described before (Wang et al., 2009 ). Real-time TaqMan PCR was then carried out using an ABI 7500 Real Time PCR system (Applied Biosystems) at concentrations of primers and probes at 900 nm and 200 nm, respectively. Two microliters of target cDNA was used in a 25-μL reaction consisting of 95°C for 10 min followed by 40 cycles at 95°C for 15 s and 60°C for 1 min. The 1-step PCR assay was carried out using TaqMan 1-step RT-PCR master mix reagents kit following the manual instruction (Applied Biosystems).
The specificity of the assay for H3N2 subtype influenza A viruses was initially evaluated using RNA from 5 cultured seasonal H3N2 viruses from 1968 to 2008, two 2009 seasonal H1N1 viruses, two 2009 pandemic H1N1 viruses (Memoli et al., 2009 (Memoli et al., , 2010a , and 9 H1N1 swine and avian viruses. HPAI virus A/ Viet Nam/1203/04 (H5N1) was also used for testing the specificity of H3N2 probe in this study. Although the H3N2 primers and probe were specifically designed from alignments of recent (2007) (2008) (2009) ) H3N2 influenza A virus sequences, it was able to amplify a wide range of seasonal H3N2 viruses from 1995 to 2010 (Fig. 1A) . Because of the substantial amount of antigenic drift that has occurred in H3N2 virus hemagglutinin since 1968, the H3N2 MGB assay did not detect the 1968 pandemic H3N2 virus [A/Hong Kong/1/1968 (H3N2)].
RNA was also isolated from the primary clinical isolates in shell vial culture from patient nasal wash samples and were also tested for H3N2 specificity in this study for ensuring the clinical applicability of this MGBbased real-time assay (Fig. 1A) . Samples, including 3 confirmed H3N2 viruses, 3 confirmed seasonal H1N1 viruses, and 2 pandemic H1N1 viruses, were collected with the consent of participants under an institutional review board-approved protocol, "Influenza in the NonImmunocompromised and Immunocompromised Host" (clinicaltrials.gov identifier: NCT00533182). Only the H3N2 samples were specifically amplified. Both 1-step PCR and 2-step PCR methods were used for the specificity detection on all cultured influenza A viruses and clinical samples, and similar results were achieved for the specific amplifications.
The sensitivity and dynamic range test for this MGBbased H3N2 assay was evaluated by testing 10-fold serial dilutions (10 8 -10 0 copies/μL) of standard template to create a standard curve for quantitative analysis (Fig. 1B) . The positive threshold for detection was determined as C T value b35. A strong correlation between the log 10 of the DNA copy number and the C T values was observed (r 2 = 0.998 and r 2 = 0.996 for 2 independent experiments). The detection limit was calculated to be 1.65 × 10 1 copy/reaction (Fig. 1B) . With the use of H3N2 viral RNA, the detection limit was shown to be 6 fg RNA (2-step RT-PCR) and 0.6 pg RNA (1-step RT-PCR).
In summary, we report here a sensitive and specific method for the rapid detection of seasonal H3N2 influenza A virus. This assay should thus provide a useful tool for differential diagnosis of seasonal H3N2 virus from other currently circulating influenza A virus subtypes. 
